Lanese D M, Yuan B H, McMurtry I F, Conger J D
Department of Medicine, University of Colorado Health Sciences Center, Denver.
Am J Physiol. 1992 Nov;263(5 Pt 2):F894-9. doi: 10.1152/ajprenal.1992.263.5.F894.
The specific intrarenal sites and mechanism of endothelin (ET) vascular action are controversial. In this study afferent (AA) and efferent arterioles (EA) were isolated from the kidneys of normal Sprague-Dawley rats. Their respective concentration-dependent changes in lumen diameter in response to ET-1 were compared with those of angiotensin II (ANG II) and norepinephrine (NE). In a second series of experiments, the duration of vasoconstriction to comparable transient submaximal ET-1, ANG II, and NE concentrations in AA and EA was examined. The role of angiotensin II in mediating endothelin vasoconstriction also was examined with the converting-enzyme inhibitor captopril (CAP) and the competitive inhibitor [Sar1,Ala8]ANG II (SAR). The half-maximal constriction concentration (EC50) of ET-1 was less in EA than AA (P < 0.01). EC50 of ET-1 in AA was similar to that of ANG II, but was less than that of NE (P < 0.001). In EA the EC50 of ET-1 was also similar to that of ANG II, but much less than that of NE (P < 0.001). In both AA and EA the duration of ET-1 constriction was at least twice that of ANG II and more than fivefold that of NE. Neither CAP (10(-6) M) nor SAR (10(-7) M) changed the vasoconstrictor response to submaximal concentrations of ET-1 in AA or EA. It is concluded that ET-1 is a potent and prolonged constrictor agonist with a small, but significantly greater, concentration-dependent effect in EA than AA. The constrictor effect of ET-1 does not require ANG II activity.
内皮素(ET)血管作用的具体肾内位点和机制存在争议。在本研究中,从正常Sprague-Dawley大鼠的肾脏中分离出入球小动脉(AA)和出球小动脉(EA)。将它们对ET-1的管腔直径各自的浓度依赖性变化与血管紧张素II(ANG II)和去甲肾上腺素(NE)的变化进行比较。在第二系列实验中,检测了AA和EA对相当的短暂次最大浓度的ET-1、ANG II和NE的血管收缩持续时间。还使用转化酶抑制剂卡托普利(CAP)和竞争性抑制剂[Sar1,Ala8]ANG II(SAR)研究了血管紧张素II在介导内皮素血管收缩中的作用。ET-1在EA中的半数最大收缩浓度(EC50)低于AA(P < 0.01)。ET-1在AA中的EC50与ANG II相似,但低于NE(P < 0.001)。在EA中,ET-1的EC50也与ANG II相似,但远低于NE(P < 0.001)。在AA和EA中,ET-1收缩的持续时间至少是ANG II的两倍,是NE的五倍多。CAP(10^(-6) M)和SAR(10^(-7) M)均未改变AA或EA对次最大浓度ET-1的血管收缩反应。得出的结论是,ET-1是一种强效且持久的收缩激动剂,在EA中具有比AA小但明显更大的浓度依赖性效应。ET-1的收缩效应不需要ANG II活性。